Multifaceted intervention to improve diagnosis and treatment of osteoporosis in patients with recent wrist fracture: a randomized controlled trial

Majumdar, Sumit R.; Johnson, Jeffrey A.; McAlister, Finlay A.; Bellerose, Debbie; Russell, Anthony S.; Hanley, David A.; Morrish, Don W.; Maksymowych, Walter P.; Rowe, Brian H.
February 2008
CMAJ: Canadian Medical Association Journal;2/26/2008, Vol. 178 Issue 5, p569
Academic Journal
The article investigates the efficiency of a multifaceted intervention designed to improve osteoporosis diagnosis and treatment in older patients with recent wrist fracture. The authors compare the efficiency of the intervention with usual osteoporosis care on patients over 50 years old, who experienced wrist fracture and were seen at emergency departments and fracture clinics, but are not being treated for osteoporosis. The primary outcome was biphosphonate treatment and secondary outcomes include bone mineral density testing within six months after the fracture. Results show that the intervention significantly increased testing and treatment rates for osteoporosis.


Related Articles

  • European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Kanis, J.; Burlet, N.; Cooper, C.; Delmas, P.; Reginster, J.-Y.; Borgstrom, F.; Rizzoli, R. // Osteoporosis International;Apr2008, Vol. 19 Issue 4, p399 

    Guidance is provided in a European setting on the assessment and treatment of postmenopausal women with or at risk from osteoporosis. The European Foundation for Osteoporosis and Bone disease (subsequently the International Osteoporosis Foundation) published guidelines for the diagnosis and...

  • In elderly men and women treated for osteoporosis a low creatinine clearance of <65 ml/min is a risk factor for falls and fractures. Dukas, Laurent; Schacht, Erich; Stähelin, Hannes // Osteoporosis International;Dec2005, Vol. 16 Issue 12, p1683 

    Recently, a low creatinine clearance (CrCl) of <65 ml/min was described as a new significant and independent risk factor for the number of fallers and falls in a community-dwelling elderly population. In this study we investigated if a low creatinine clearance of <65 ml/min is also a risk factor...

  • A rare case of a bisphosphonate-related femoral diaphyseal fracture occurring below a previously fixed compression hip screw (CHS) plate. Cho, Hyung; Suh, Kuen // Journal of Orthopaedic Science;May2015, Vol. 20 Issue 3, p559 

    The article describes the case of a rare case of a bisphosphonate-related femoral diaphyseal fracture happening below a formerly fixed compression hip screw (CHS) plate. Biphosphonates have been ubiquitously used for the treatment of osteoporosis and have proven effectiveness in lessening the...

  • Osteoporosis.  // Current Medical Literature: Rheumatology;2008, Vol. 27 Issue 4, p113 

    This section presents abstracts of two studies related to osteoporosis, including the effectiveness of osteoporosis drugs to prevent nonvertebral fracture, and the use of osteoporosis medication in nursing home patients with fractures.

  • Diagnosis and assessment.  // WHO Technical Report Series;2003, Issue 921, p53 

    Discusses diagnostic methods for osteoporosis. Methods of measuring bone mass and density; Assessment of fracture risk; Risk factors for osteoporosis.

  • Alendronate treatment of established primary osteoporosis in men: 3-year results of a prospective, comparative, two-arm study. Ringe, J. D.; Dorst, A.; Faber, H.; Ibach, K. // Rheumatology International;Mar2004, Vol. 24 Issue 2, p110 

    Our trial was a 3-year, open-label, prospective, comparative, clinical study comparing the effects of oral alendronate (ALN), 10 mg daily, and alfacalcidol (AC), 1 μg daily, on bone mineral density (BMD), fracture events, height, back pain, safety and tolerability in 134 men with established...

  • Do bisphosphonates reduce the risk of osteoporotic fractures? An evaluation of the evidence to date. Hodsman, Anthony B.; Hanley, David A.; Josse, Robert // CMAJ: Canadian Medical Association Journal;5/28/2002, Vol. 166 Issue 11, p1426 

    Discusses whether bisphosphonates reduce the risk of osteoporotic fractures. Mortality from bone fractures in the elderly; Fracture rates among patients with osteoporosis; Indication that bisphosphonates increase bone mineral density; Expected reduction in morbidity and mortality.

  • Osteoporosis.  // Current Medical Literature: Rheumatology;2008, Vol. 27 Issue 1, p21 

    The article discusses research being done on the use of a case manager to improve osteoporosis treatment after hip fracture. It references a study by S. R. Majumdar et al., published on a 2007 issue of the journal "Archives of Internal Medicine." The study found that the proactive use of a case...

  • TRATAMIENTO CON BISFOSFONATOS Y FRACTURAS ATIPICAS. Spivacow, Francisco R.; Sarli, Marcelo; Buttazzoni, Mirena // Medicina (Buenos Aires);2009, Vol. 69 Issue 6, p612 

    In the last twenty five years aminobisphosphonates have became the drugs of choice for the treatment of osteoporosis. They strongly inhibit osteoclastic bone resorption and reduce the incidence of new fractures in patients with established osteoporosis, but their long half-life and their chronic...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics